A Seminal Multicentric Study
Doug Kondziolka came to me with a short series of patients who had been treated less successfully in Pittsburgh using a lower dose of radiation. He proposed that we combine our two series for a publication demonstrating the dose effect in treating trigeminal neuralgia. Some months later, after we had added more cases from Rhode Island and Seattle, we were able to publish, in the Journal of Neurosurgery (JNS) , what is now considered a seminal paper demonstrating for the first time the safety efficacy of GKS at maximum doses between 70 and 90 Gy. 10 That paper initiated a profound change in radiosurgical practice, which rapidly translated into more patients undergoing radiosurgery ( Fig. 1) and a large number of papers documenting its safety efficacy (Figs. [2] [3] [4] . Interestingly, many key papers were also published in JNS (Fig. 4) .
The Major Contribution of JNS to the Establishment of Gamma Knife Surgery
This supplement contains the 25 most frequently cited articles in JNS on GKS for trigeminal neuralgia according to a recent search of Web of Science. The majority of these "Top 25" papers have made great scientific contributions to the field. Soon after the multiinstitutional study was published in 1996, 10 good short-term safety efficacy of GKS was confirmed by three studies of large cohorts of patients treated using the so-called DREZ target (site of the dorsal root entry zone). 14, 22, 30 These papers established better long-term results in patients who had not previously undergone surgery. However, globally, papers in the literature frequently report results based on very heterogeneous methodologies. Because the effect of radiosurgery is delayed, efficacy can be appreciated very differently if authors report only initial pain cessation, with or without medication, rather than long-term freedom from pain without medication (Table 1) . Sometimes Fifteen years of Gamma Knife surgery for trigeminal neuralgia in the Journal of Neurosurgery: history of a revolution in functional neurosurgery patients who no longer feel pain are mixed with patients who have more than a 90% reduction in the number of pain attacks! We consider it mandatory to report patients who are free from pain, with or without medication, separately from patients whose pain has improved but has not completely ceased. Additionally, rates of recurrence after surgery (whatever the approach) are significant, and authors must report Kaplan-Meier rates of pain freedom at 1, 2, 3, or more years instead of freedom from pain at the last follow-up. The only prospective trial published to date was one published in JNS by our group in 2006. 29 That paper fulfills all the major criteria for "quality reporting in surgery for trigeminal neuralgia," specified by Zakrzewska in 2003, 34 with the exception of minimum follow-up, which was 1 year in the paper.
Nuances in Technique Make Significant Differences in Clinical Results
In the early 1990s, thanks to magnetic resonance imaging, Rand 24 proposed to move the radiosurgical target from the ganglion to the cisternal segment of the nerve. Christer Lindquist then promoted the elegant idea of targeting the DREZ by directing a 4-mm shot at the site where the trigeminal nerve emerges from the pons and by overlapping generously the adjacent brainstem. 1 Because the site where the myelin sheath of peripheral sensory nerves shifts from a composition of Schwann cells to one of oligodendrocytes is a classic target in pain surgery, this idea made a lot of sense and became very popular. However, in our group we were concerned about the potential risk of brainstem injury, which led us to propose a more anterior target, 7 -8 mm anterior to the emergence of the nerve from the pons, coined the "retrogasserian target." 26, 29 In the prospective trial the safety efficacy of the procedure using an average dose of 85 Gy and a retrogasserian target compared favorably to that of a series in which the radiation dose was lower and the target the DREZ. 29 The potential benefit of these technical nuances to avoid source shielding, 16 which can lead to an increased rate of hypesthesia according to the "Flickinger effect," has been confirmed by several other papers in the Top 25. 15, 18 In a comparison of one-shot and two-shot strategies, John Flickinger and the Pittsburgh team demonstrated that increasing the volume of the fifth cranial nerve that is treated leads to a dramatic increase in the risk of toxicity with no clear benefit in efficacy. 6 Brisman and Pollock and colleagues showed that the use of a low dose (75 Gy) on the DREZ target requires being more aggressive to the brainstem in order to achieve good short-term efficacy. 3, 19, 21, 25 Consequently, maximum dose, volume of nerve treated, and anatomical location of the target (and hence the dose to the intraaxial portion of fifth nerve fibers in the brainstem) are technical nuances of radiosurgery that have a major impact on both the probability of long-term pain control and the probability and severity of fifth cranial nerve disturbance.
Defining the Limits
Our group 28 and that of Chang 4 reported high rates of pain relief in patients who underwent radiosurgery for secondary trigeminal neuralgia. The safety efficacy of a second radiosurgical treatment was reported in 2000 by Pollock and colleagues 20 and again in 2002 by Shetter et al. 32 According to the former group, much better efficacy is associated with the first radiosurgical intervention. 20 Atypical trigeminal neuralgia, not surprisingly, has been described to respond less favorably to radiosurgery, with both a lower chance of satisfactory pain relief and a greater risk of worsening a neuropathic mode.
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The Least-Invasive Surgical Technique for Tic Douloureux
The only complication reported in these papers was a more-or-less disabling disturbance in trigeminal nerve function, including dry eye in the 2002 study by Matsuda et al. 17 An "evidence-based" review of the literature published in Neurology by the Federation of Neurological Societies clearly established that in the literature the rate of hypesthesia following MVD is not significantly different from that after GKS, although the rate is much lower than the one associated with percutaneous treatments. 7 Other complications (cerebellar lesion, CSF leak, aseptic or bacterial meningitis, diplopia, deafness, facial palsy, and others) associated with MVD and/or percutaneous treatments have not been reported following radiosurgery. 7 
Hypesthesia is Not Necessary for a Long-Lasting Effect!
Clearly the small subgroup of patients with hypesthesia has a higher probability of long-lasting pain relief, 19 but what is more important is that the vast majority of patients experiencing long-term pain control do not experience any kind of trigeminal nerve dysfunction. 5, 11, 29 Contrary to destructive techniques of treating trigeminal neuralgia, such as thermocoagulation, balloon microcompression, and glycerol injection, with radiosurgery hypesthesia is not mandatory for durable efficacy.
Long-Term Safety Efficacy
Importantly, Dhople et al. 5 and Kondziolka and colleagues 11 reported their long-term results (> 100 patients with a follow-up > 5 years for Kondziolka's series). Using the DREZ as the target with quite low radiation doses, both teams reported a steady rate of late failure: for Dhople et al. 22% of patients remained pain free at 7 years, and for Kondziolka and colleagues 30% of patients at 10 years had Barrow Neurological Institute Scale Scores I through IIIb. 31 Long-term results with high radiation doses and the anterior cistern as the target have not yet been published.
Microvascular Decompression
Microvascular decompression remains the reference technique for the majority of authors, despite the fact that in the absence of a serious prospective randomized comparative trial (with a sufficiently large population and lengthy follow-up) no definitive statement can be made concerning the superiority of one technique over the other. However, if both MVD and GKS have very significant rates of long-term recurrences, the probability of being pain free without medication looks better in the MVD group. 13, 23 The majority of authors who have at their disposal the technical and human resources allowing them to offer MVD, GKS, and percutaneous techniques agree that the current evidence for the long-term safety efficacy of GKS is sufficient to propose GKS as the first intervention. 5, 9, 11, 29 Advantages and disadvantages of each technique must be disclosed to the patient, as advocated in modern serious peer-reviewed series published in the last 16 years.
In conclusion, this series of the Top 25 papers in JNS on GKS for trigeminal neuralgia bears witness to the fact that radiosurgery is an example of a true disruptive innovation in the field of functional neurosurgery and, specifically, in the neurosurgical management of trigeminal neuralgia. These articles demonstrate how greatly this innovation has changed neurosurgical practice in just a few years.
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